GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022)

GoodRx Holdings (GDRX) posted Non-Current Deferred Tax Liability of $650000.0 for Q3 2022, up 42.86% sequentially from $455000.0 in Q2 2022.

GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022) Analysis & Trends

GoodRx Holdings has reported Non-Current Deferred Tax Liability for 3 years, with the latest figure at $650000.0 in Q3 2022.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $650000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $650000.0 (changed N/A YoY) and the FY2021 annual result came in at $244000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability advanced to $650000.0 in Q3 2022 per GDRX's latest filing, from $455000.0 in the prior quarter.
Over five years, Non-Current Deferred Tax Liability peaked at $1.8 million in Q3 2020 and troughed at $244000.0 in Q4 2021.
A 3-year average of $703600.0 and a median of $455000.0 in 2022 frame the typical range for Non-Current Deferred Tax Liability.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	GoodRx Holdings	1.27 Bn	972.56 Mn	179.41 Mn

Download Data